CompletedPhase 3NCT00844402

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

Studying Primary biliary cholangitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Medical University of Graz
Principal Investigator: Michael Trauner, M.D.
Medical University of Graz, Department of Internal Medicine
Intervention: Atorvastatin(drug)
Enrollment: 40 target
Eligibility: 18-70 years · All sexes
Timeline: 2006 – 2007

Study locations (1)

Department of Internal Medicine, Medical University of Graz, Graz, Austria

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00844402 on ClinicalTrials.gov

Other trials for Primary biliary cholangitis

Additional recruiting or active studies for the same condition.

See all trials for Primary biliary cholangitis →

← Back to all trials